NeuroOne Medical Technologies Corporation
NMTC
$0.75
$0.011.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 238.48% | 22.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 238.48% | 22.32% | |||
| Cost of Revenue | 18.67% | 193.05% | |||
| Gross Profit | 1,374.04% | -137.36% | |||
| SG&A Expenses | 10.05% | -16.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 98.51% | -11.90% | |||
| Operating Income | 27.32% | 29.60% | |||
| Income Before Tax | -7.88% | 33.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.88% | 33.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.88% | 33.90% | |||
| EBIT | 27.32% | 29.60% | |||
| EBITDA | 28.20% | 30.39% | |||
| EPS Basic | -4.53% | 57.67% | |||
| Normalized Basic EPS | 72.22% | 56.26% | |||
| EPS Diluted | -4.53% | 57.67% | |||
| Normalized Diluted EPS | 72.22% | 56.26% | |||
| Average Basic Shares Outstanding | 2.99% | 56.23% | |||
| Average Diluted Shares Outstanding | 2.99% | 56.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||